Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 4Breast Neoplasms 3Prostatic Neoplasms 2Melanoma 2Healthy Participants 2Carcinoma, Non-Small-Cell Lung 2Advanced Solid Tumor 2cMET-dysregulated Advanced Solid Tumors 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Solid Tumor 1Neoplastic Cells, Circulating 1Liver Cirrhosis 1Drug-drug Interaction,SHR3680 1

Interventions

senaparib 7pembrolizumab 7Irinotecan 6Paclitaxel 5Docetaxel 5Cisplatin 5Capecitabine 5Nivolumab 4Fluorouracil 4Bevacizumab 4Rifampin 3Midazolam 3Leucovorin 3Itraconazole 3Injections 3pertuzumab 2ontuxizumab 2navoximod 2atezolizumab 2Gemcitabine 2vofatamab 1tremelimumab 1trastuzumab duocarmazine 1talazoparib 1sotorasib 1sintilimab 1saracatinib 1rucaparib 1ridaforolimus 1regorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Solid Tumor × Digoxin × Clear all
NCT05357911 2024-11-21

A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin

Nuvation Bio Inc.

Phase 1 Completed
16 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡